Jetema Co

Jetema Co Net Debt per Share

The Net Debt per Share of Jetema Co (216080.KQ) as of Oct 23, 2026 is 1,402.17 KRW. In the previous year, Net Debt per Share was 2,664.64 KRW — a change of -47.38% (lower).

Net Debt per Share

1,402.17KRW

YoY

-47.38%

Last updated:

Net Debt per Share of Jetema Co is 2025 1,402.17 KRW. Net Debt per Share of Jetema Co was 2024 2,664.64 KRW. It decreases by -47.38% lower compared to the previous year.

The Jetema Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
128.06 KRW
Jan 1, 2019
126.77 KRW
Jan 1, 2020
-32.14 KRW
Jan 1, 2021
-498.73 KRW
Jan 1, 2022
2,421.90 KRW
Jan 1, 2023
2,149.92 KRW
Jan 1, 2024
2,664.64 KRW
Jan 1, 2025
1,402.17 KRW
The Jetema Co Net Debt per Share history
YEARNet Debt per ShareYoY
1,402.17KRW-47.38%
2,664.64KRW+23.94%
2,149.92KRW-11.23%
2,421.90KRW-585.62%
-498.73KRW+1,451.55%
-32.14KRW-125.36%
126.77KRW-1.01%
128.06KRW-54.07%
278.81KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jetema Co Stock analysis

What does Jetema Co do? Jetema Co., Ltd. generates revenue through the manufacturing and distribution of aesthetic products such as dermal fillers, threads, botulinum toxin, and other medical devices. The company develops and sells hyaluronic acid fillers for facial beauty, medical devices for wrinkle, contour, and volume improvement, and laser equipment for treating leukoplakia, psoriasis, and alopecia areata. Additional products include the lifting medical device epiticons, cosmetic mask packs, and pharmaceutical excaine creams. The primary buyers are medical professionals and clinics seeking cosmetic and dermatological solutions. The company's product portfolio targets the aesthetic and medical device market segments, focusing on non-surgical beauty treatments and skin condition therapies. Jetema Co., Ltd. serves customers in the healthcare sector who require advanced medical devices for cosmetic procedures and dermatological care. The business model centers on direct sales of these specialized medical products to healthcare providers and clinics. Jetema Co., Ltd. operates with a workforce of 187 full-time employees based in Wonju, Gangwon-Do, and has been engaged in the development and manufacturing of hyaluronic acid fillers since its inception. The company's offerings are designed to address specific medical and cosmetic needs, with a focus on facial beauty and skin treatments. Revenue is derived from the sale of these medical devices and related products to healthcare professionals and clinics. Jetema Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jetema Co stock

Net Debt per Share of Jetema Co is 1,402.17 KRW in 2025.

Net Debt per Share of Jetema Co changed from 2,664.64 KRW to 1,402.17 KRW, representing a -47.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Jetema Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Jetema Co

All Key Metrics — Jetema Co